Featured publications

• Early treatment with JNJ-46356479, a mGluR2 modulator, improves behavioral and neuropathological deficits in a postnatal ketamine mouse model of schizophrenia

  Martinez-Pinteno, A; Rodriguez, N; Olivares, D; Madero, S; Gomez, M;

  (...)

  Garcia-Rizo, C; Mas, S; Moren, C; Parellada, E; Gasso, P.

  See complete list of authors

  Reference:

  Biomedicine & Pharmacotherapy 2023.

• Deep brain stimulation and digital monitoring for patients with treatment-resistant schizophrenia and bipolar disorder: A case series

  Bioque M; Rumià J; Roldán P; Hidalgo-Mazzei D; Montejo L;

  Benabarre A; Gil-Badenes J; Tercero J; Parellada E; Vieta E.

  Reference:

  Revista De Psiquiatria Y Salud Mental 2023.

• Dried Blood Spot (DBS) as a useful tool to improve clozapine, aripiprazole and paliperidone treatment: From adherence to efficiency

  Bernardo, M; Mezquida, G; Ferré, P; Cabrera, B; Torra, M;

  Lizana, AM; Brunet, M.

  Reference:

  Revista De Psiquiatria Y Salud Mental 2022.

• Mapping Retinal Abnormalities in Psychosis: Meta-analytical Evidence for Focal Peripapillary and Macular Reductions

  Gonzalez-Diaz, Jairo M; Radua, Joaquim; Sanchez-Dalmau, Bernardo; Camos-Carreras, Anna; Zamora, Diana C;

  Bernardo, Miquel.

  Reference:

  Schizophrenia Bulletin 2022.

• Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort.

  Mas, S; Gasso, P; Rodriguez, N; Cabrera, B; Mezquida, G;

  (...)

  Butjosa, Anna; Pardo, Marta; Pomarol-Clotet, Edith; Ibanez Cuadrado, Angela; Cuesta, Manuel J.

  See complete list of authors

  Reference:

  Acta Psychiatrica Scandinavica 2020.

• Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

  Garcia-Rizo, Clemente; Bioque, Miquel; Mezquida, Gisela; Amoretti, Silvia; Cuesta, Manuel J;

  (...)

  Sarro, Salvador; Pomarol-Clotet, Edith; Ibanez, Angela; Sanchez-Torres, Ana M; Selva-Vera, Gabriel.

  See complete list of authors

  Reference:

  Schizophrenia Research 2020.

• CLOZAPINE AND PALIPERIDONE PALMITATE ANTIPSYCHOTIC COMBINATION IN TREATMENT-RESISTANT SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS: A RETROSPECTIVE 6-MONTH MIRROR-IMAGE STUDY

  Bioque, Miquel; Parellada, Eduard; Garcia-Rizo, Clemente; Amoretti, Silvia; Fortea, Adriana;

  Oriolo, Giovanni; Palau, Pol; Boix-Quintana, Ester; Safont, Gemma; Bernardo, Miquel.

  Reference:

  European Psychiatry 2020.

• One decade of the first episodes project (PEPs): Advancing towards a precision psychiatry

  Bernardo, M; Cabrera, B; Arango, C; Bioque, M; Castro-Fornieles, J;

  Cuesta, MJ; Lafuente, A; Parellada, M; Saiz-Ruiz, J; Vieta, E.

  Reference:

  Revista De Psiquiatria Y Salud Mental 2019.

• A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments

  Arranz, Maria J.; Gonzalez-Rodriguez, Alex; Perez-Blanco, Josefina; Penades, Rafael; Gutierrez, Blanca;

  (...)

  Arias, Barbara; Brunet, Merce; Cervilla, Jorge; Salazar, Juliana; Catalan, Rosa;.

  See complete list of authors

  Reference:

  Translational Psychiatry 2019.

• BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trial

  Penades, Rafael; Lopez-Vilchez, Irene; Catalan, Rosa; Arias, Barbara; Gonzalez-Rodriguez, Alexandre;

  Garcia-Rizo, Clemente; Masana, Guillem; Ruiz, Victoria; Mezquida, Gisela; Bernardo, Miquel.

  Reference:

  Schizophrenia Research 2018.